Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial Supplement 1. Supplement 2. eFigure 1. Number of Participants with Defined Components of Exacerbation during the MINT RCP eFigure 2. Annualized Exacerbation Rate eFigure 3. Swimmer Plots of Participants with Exacerbation during the MINT RCP eTable. Time to First Exacerbation by Week 26 (Full Analysis Set: MuSK+ Subpopulation) Supplement 3. Figure 1.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile